Midodrine
Vasopressor/antihypotensive agent / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Midodrine?
Summarize this article for a 10 year old
Midodrine is a vasopressor/antihypotensive agent (it raises the blood pressure). Midodrine was approved in the United States by the Food and Drug Administration (FDA) in 1996 for the treatment of dysautonomia and orthostatic hypotension. In August 2010, the FDA proposed withdrawing this approval because the manufacturer, Shire plc, failed to complete required studies after the medicine reached the market.[2][3] In September 2010, the FDA reversed its decision to remove midodrine from the market and allowed it to remain available to patients while Shire plc collected further data regarding the efficacy and safety of the drug.[4] Shire announced on September 22, 2011, that it was withdrawing completely from supplying midodrine. Several Indian generic drug manufacturers now produce the world's supply of midodrine tablets.[5]
Clinical data | |
---|---|
Trade names | Amatine, Proamatine, Gutron, others |
Other names | 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]-acetamide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a602023 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.151.349 100.050.842, 100.151.349 |
Chemical and physical data | |
Formula | C12H18N2O4 |
Molar mass | 254.286 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
NY (what is this?) (verify) |